As expected, lower MMSE scores as well as lower levels of Aβ42 and higher levels of t-tau and p-tau in the CSF were found in patients with AD as compared to patients with MCI and SCI (Figure 4B). This evidence concerns the gene MAPT and Alzheimer disease.